Curated News Summary
Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research
Why This Matters
Key context: Prediction markets on Kalshi and Polymarket now let people wager money on drug approvals. Kalshi also plans to allow bets on clinical trial results. This development from The New York Times highlights ongoing changes in the sector.
Prediction markets on Kalshi and Polymarket now let people wager money on drug approvals. Kalshi also plans to allow bets on clinical trial results.
Curation & Context
This page summarizes a public news report from The New York Times. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.